| Primary |
| Multiple Sclerosis |
89.3% |
| Product Used For Unknown Indication |
1.9% |
| Relapsing-remitting Multiple Sclerosis |
1.6% |
| Crohn's Disease |
1.0% |
| Drug Use For Unknown Indication |
0.9% |
| Depression |
0.8% |
| Pain |
0.8% |
| Premedication |
0.6% |
| Hypertension |
0.4% |
| Muscle Spasticity |
0.4% |
| Fatigue |
0.3% |
| Muscle Spasms |
0.3% |
| Anxiety |
0.3% |
| Convulsion |
0.2% |
| Gait Disturbance |
0.2% |
| Neuralgia |
0.2% |
| Insomnia |
0.2% |
| Prophylaxis |
0.2% |
| Headache |
0.2% |
| Migraine |
0.1% |
|
| Multiple Sclerosis Relapse |
14.2% |
| Fatigue |
11.4% |
| Urinary Tract Infection |
8.4% |
| Multiple Sclerosis |
5.9% |
| Headache |
5.9% |
| Malaise |
5.7% |
| Drug Ineffective |
4.5% |
| Gait Disturbance |
4.5% |
| Nasopharyngitis |
4.4% |
| Memory Impairment |
4.2% |
| Pain In Extremity |
3.7% |
| Progressive Multifocal Leukoencephalopathy |
3.7% |
| Pain |
3.5% |
| Muscular Weakness |
3.2% |
| Asthenia |
3.1% |
| Stress |
3.0% |
| Visual Impairment |
3.0% |
| Fall |
2.7% |
| Tremor |
2.5% |
| Sinusitis |
2.5% |
|
| Secondary |
| Multiple Sclerosis |
90.2% |
| Product Used For Unknown Indication |
1.8% |
| Relapsing-remitting Multiple Sclerosis |
1.8% |
| Crohn's Disease |
0.9% |
| Depression |
0.8% |
| Pain |
0.8% |
| Drug Use For Unknown Indication |
0.6% |
| Premedication |
0.5% |
| Hypertension |
0.3% |
| Muscle Spasticity |
0.3% |
| Fatigue |
0.3% |
| Muscle Spasms |
0.2% |
| Gastrooesophageal Reflux Disease |
0.2% |
| Anxiety |
0.2% |
| Insomnia |
0.2% |
| Sleep Disorder |
0.2% |
| Migraine |
0.2% |
| Gait Disturbance |
0.1% |
| Hypothyroidism |
0.1% |
| Bone Marrow Failure |
0.1% |
|
| Multiple Sclerosis Relapse |
17.4% |
| Urinary Tract Infection |
9.0% |
| Fatigue |
8.5% |
| Multiple Sclerosis |
8.1% |
| Malaise |
6.8% |
| Gait Disturbance |
5.1% |
| Memory Impairment |
4.2% |
| Visual Impairment |
4.0% |
| Headache |
3.8% |
| Nasopharyngitis |
3.8% |
| Drug Ineffective |
3.7% |
| Pain |
3.4% |
| Stress |
3.3% |
| Asthenia |
3.2% |
| Pain In Extremity |
3.2% |
| Muscular Weakness |
2.8% |
| Fall |
2.7% |
| Tremor |
2.6% |
| Sinusitis |
2.4% |
| Vomiting |
2.3% |
|
| Concomitant |
| Multiple Sclerosis |
77.1% |
| Product Used For Unknown Indication |
8.1% |
| Relapsing-remitting Multiple Sclerosis |
3.2% |
| Gait Disturbance |
2.4% |
| Crohn's Disease |
2.0% |
| Pain |
1.0% |
| Depression |
0.8% |
| Drug Use For Unknown Indication |
0.5% |
| Fatigue |
0.5% |
| Diabetes Mellitus |
0.5% |
| Progressive Multiple Sclerosis |
0.5% |
| Vitamin Supplementation |
0.5% |
| Neuralgia |
0.5% |
| Premedication |
0.4% |
| Muscle Spasms |
0.4% |
| Inflammatory Bowel Disease |
0.4% |
| Asthma |
0.3% |
| Bladder Disorder |
0.3% |
| Chronic Obstructive Pulmonary Disease |
0.3% |
| Anxiety |
0.3% |
|
| Multiple Sclerosis Relapse |
12.1% |
| Multiple Sclerosis |
7.7% |
| Tremor |
6.7% |
| Nausea |
6.0% |
| Vomiting |
6.0% |
| Drug Ineffective |
5.3% |
| Influenza Like Illness |
4.9% |
| Pruritus |
4.9% |
| Urinary Tract Infection |
4.9% |
| Visual Impairment |
4.6% |
| Memory Impairment |
4.4% |
| Gait Disturbance |
4.2% |
| Convulsion |
3.9% |
| Flushing |
3.9% |
| Suicidal Ideation |
3.7% |
| General Symptom |
3.5% |
| Weight Increased |
3.5% |
| Fatigue |
3.2% |
| Muscular Weakness |
3.2% |
| Pain |
3.2% |
|
| Interacting |
| Multiple Sclerosis |
66.7% |
| Claustrophobia |
33.3% |
|
|
